Status: Bibliographieeintrag
Standort: ---
Exemplare:
---
| Titel: | Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer |
|---|
| Mitwirkende: | Heinemann, Volker  |
|---|
| | Ebert, Matthias |
|---|
| Verf.angabe: | Heinemann, V.; Ebert, M. P. ... |
|---|
| Jahr: | 2013 |
|---|
| Umfang: | 5 S. |
|---|
| Titel Quelle: | In: The British journal of cancer |
|---|
| Ort Quelle: | Basingstoke : Nature Publishing Group, 1947 |
|---|
| Jahr Quelle: | 2013 |
|---|
| Band/Heft Quelle: | 108(2013), 4, Seite 766-770 |
|---|
| ISSN Quelle: | 0007-0920 |
|---|
| Sprache: | eng |
|---|
| K10plus-PPN: | 1631845691 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer / Heinemann, Volker; 2013
67401203
